Patents by Inventor Peter Noy

Peter Noy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of the interaction between CLEC14A and multimerin-2 for inhibition of angiogenesis
    Patent number: 11919959
    Abstract: The invention provides a method of inhibiting angiogenesis in an individual, the method comprising administering to the individual an agent that inhibits the interaction between CLEC14A and MMRN2. The inhibitor may be an antibody, a polypeptide, a peptide, a polynucleotide, a peptidomimetic, a natural product, a carbohydrate, an aptamer or a small molecule.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: March 5, 2024
    Assignee: Cancer Research Technology Limited
    Inventors: Roy Bicknell, Peter Noy, Kabir Ali Khan
  • Inhibitors of the Interaction Between CLEC14A and Multimerin-2 for Inhibition of Angiogenesis
    Publication number: 20210070867
    Abstract: The invention provides a method of inhibiting angiogenesis in an individual, the method comprising administering to the individual an agent that inhibits the interaction between CLEC14A and MMRN2. The inhibitor may be an antibody, a polypeptide, a peptide, a polynucleotide, a peptidomimetic, a natural product, a carbohydrate, an aptamer or a small molecule.
    Type: Application
    Filed: August 13, 2020
    Publication date: March 11, 2021
    Applicant: Cancer Research Technology Limited
    Inventors: Roy Bicknell, Peter Noy, Kabir Ali Khan
  • Inhibitors of the interaction between CLEC14A and multimerin-2 for inhibition of angiogenesis
    Patent number: 10808031
    Abstract: The invention provides a method of inhibiting angiogenesis in an individual, the method comprising administering to the individual an agent that inhibits the interaction between CLEC14A and MMRN2. The inhibitor may be an antibody, a polypeptide, a peptide, a polynucleotide, a peptidomimetic, a natural product, a carbohydrate, an aptamer or a small molecule.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: October 20, 2020
    Assignee: Cancer Research Technology Limited
    Inventors: Roy Bicknell, Peter Noy, Kabir Ali Khan
  • INHIBITORS OF THE INTERACTION BETWEEN CLEC14A AND MULTIMERIN-2 FOR INHIBITION OF ANGIOGENESIS
    Publication number: 20180282418
    Abstract: The invention provides a method of inhibiting angiogenes—is in an individual, the method comprising administering to the individual an agent that inhibits the interaction between CLEC14A and MMNR2.
    Type: Application
    Filed: January 21, 2016
    Publication date: October 4, 2018
    Applicant: Cancer Research Technology Limited
    Inventors: Roy Bicknell, Peter Noy, Kabir Ali Khan